Schmid Timothy
EVP, WW Chair, MedTech
SaleAlert
- Shares
- 22,527
- Price
- $274.74
- Value
- $6,189,068
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•71 filings
JNJ
JOHNSON & JOHNSON
Net sales of $62M over the last 3 months
4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$61,986,737
0 buyers · 4 sellers
12-month purchases
$257,688
1 distinct insiders
12-month sales
$150,667,262
10 distinct insiders
Highlighted alerts
33
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get JNJ insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
JNJ overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
33
Voluntary view
P/S trades after deterministic checks
76
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 113.1
- Price
- $276.31
- Footnotes
- 2
Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Schmid Timothy
EVP, WW Chair, MedTech
SaleAlert
- Shares
- 11,070
- Price
- $274.74
- Value
- $3,041,372
Taubert Jennifer L
EVP, WWC. Innovative Medicine
SaleAlert
- Shares
- 15,000
- Price
- $263.36
- Value
- $3,950,400
Duato Joaquin
CEO and Chairman of the Board
SaleAlert
- Shares
- 102,315
- Price
- $261.00
- Value
- $26,704,215
Duato Joaquin
CEO and Chairman of the Board
SaleAlert
- Shares
- 20,976
- Price
- $262.00
- Value
- $5,495,712
Forminard Elizabeth
EVP, Chief Legal Officer
SaleAlert
- Shares
- 6,574
- Price
- $255.93
- Value
- $1,682,497
Forminard Elizabeth
EVP, Chief Legal Officer
SaleAlert
- Shares
- 9,344
- Price
- $257.76
- Value
- $2,408,463
Duato Joaquin
CEO and Chairman of the Board
SaleAlert
- Shares
- 6,523
- Price
- $258.74
- Value
- $1,687,755
Duato Joaquin
CEO and Chairman of the Board
SaleAlert
- Shares
- 41,957
- Price
- $258.06
- Value
- $10,827,256
Broadhurst Vanessa
EVP, Global Corp Affairs
SaleAlert
- Shares
- 23,054
- Price
- $251.27
- Value
- $5,792,686
Wengel Kathryn E
EVP, Chief TO and Risk Officer
SaleAlert
- Shares
- 10,000
- Price
- $241.15
- Value
- $2,411,500
Decker Robert J
VP Corporate Controller
SaleAlert
- Shares
- 4,075
- Price
- $247.87
- Value
- $1,010,070
Schmid Timothy
EVP, WW Chair, MedTech
SaleAlert
- Shares
- 1,322
- Price
- $245.66
- Value
- $324,763
Schmid Timothy
EVP, WW Chair, MedTech
SaleAlert
- Shares
- 13,625
- Price
- $244.20
- Value
- $3,327,225
Schmid Timothy
EVP, WW Chair, MedTech
SaleAlert
- Shares
- 8,998
- Price
- $244.53
- Value
- $2,200,281
Swanson James D.
EVP, CIO
SaleAlert
- Shares
- 20,521
- Price
- $242.70
- Value
- $4,980,447
Wolk Joseph J
Exec VP, CFO
SaleAlert
- Shares
- 19,241
- Price
- $242.99
- Value
- $4,675,371
Wolk Joseph J
Exec VP, CFO
SaleAlert
- Shares
- 24,961
- Price
- $242.68
- Value
- $6,057,535
Wolk Joseph J
Exec VP, CFO
SaleAlert
- Shares
- 33,386
- Price
- $242.75
- Value
- $8,104,452
Wolk Joseph J
Exec VP, CFO
SaleAlert
- Shares
- 12,066
- Price
- $242.87
- Value
- $2,930,469
REED JOHN C
EVP, Innovative Medicine, R&D
SaleAlert
- Shares
- 2,283
- Price
- $243.00
- Value
- $554,769
REED JOHN C
EVP, Innovative Medicine, R&D
SaleAlert
- Shares
- 29,927
- Price
- $243.00
- Value
- $7,272,261
REED JOHN C
EVP, Innovative Medicine, R&D
SaleAlert
- Shares
- 21,721
- Price
- $243.00
- Value
- $5,278,203
Broadhurst Vanessa
EVP, Global Corp Affairs
SaleAlert
- Shares
- 6,197
- Price
- $243.39
- Value
- $1,508,288
Swanson James D.
EVP, CIO
SaleAlert
- Shares
- 22,191
- Price
- $243.71
- Value
- $5,408,169
Swanson James D.
EVP, CIO
SaleAlert
- Shares
- 19,368
- Price
- $243.76
- Value
- $4,721,144
Duato Joaquin
CEO and Chairman of the Board
SaleAlert
- Shares
- 48,782
- Price
- $221.48
- Value
- $10,804,432
Duato Joaquin
CEO and Chairman of the Board
SaleAlert
- Shares
- 51,218
- Price
- $220.99
- Value
- $11,318,461
MORIKIS JOHN G
Director
PurchaseAlert
- Shares
- 1,250
- Price
- $206.15
- Value
- $257,688
REED JOHN C
EVP, Innovative Medicine, R&D
SaleAlert
- Shares
- 21,721
- Price
- $192.71
- Value
- $4,185,793
Taubert Jennifer L
EVP, WWC. Innovative Medicine
SaleAlert
- Shares
- 56,471
- Price
- $177.81
- Value
- $10,040,883
Duato Joaquin
CEO and Chairman of the Board
SaleAlert
- Shares
- 125,824
- Price
- $179.21
- Value
- $22,548,655
Wolk Joseph J
Exec VP, CFO
SaleAlert
- Shares
- 16,820
- Price
- $176.91
- Value
- $2,975,571
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 02, 2026 | Schmid Timothy EVP, WW Chair, MedTech | Sale | 22,527 | $274.74 | $6,189,068 | |
| Sep 02, 2026 | Schmid Timothy EVP, WW Chair, MedTech | Sale | 11,070 | $274.74 | $3,041,372 | |
| Aug 17, 2026 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Sale | 15,000 | $263.36 | $3,950,400 | |
| Aug 13, 2026 | Duato Joaquin CEO and Chairman of the Board | Sale | 102,315 | $261.00 | $26,704,215 | |
| Aug 13, 2026 | Duato Joaquin CEO and Chairman of the Board | Sale | 20,976 | $262.00 | $5,495,712 | |
| Aug 06, 2026 | Forminard Elizabeth EVP, Chief Legal Officer | Sale | 6,574 | $255.93 | $1,682,497 | |
| Aug 06, 2026 | Forminard Elizabeth EVP, Chief Legal Officer | Sale | 9,344 | $257.76 | $2,408,463 | |
| Aug 05, 2026 | Duato Joaquin CEO and Chairman of the Board | Sale | 6,523 | $258.74 | $1,687,755 | |
| Aug 05, 2026 | Duato Joaquin CEO and Chairman of the Board | Sale | 41,957 | $258.06 | $10,827,256 | |
| Jul 20, 2026 | Broadhurst Vanessa EVP, Global Corp Affairs | Sale | 23,054 | $251.27 | $5,792,686 | |
| Jun 11, 2026 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Sale | 10,000 | $241.15 | $2,411,500 | |
| Feb 27, 2026 | Decker Robert J VP Corporate Controller | Sale | 4,075 | $247.87 | $1,010,070 | |
| Feb 20, 2026 | Schmid Timothy EVP, WW Chair, MedTech | Sale | 1,322 | $245.66 | $324,763 | |
| Feb 18, 2026 | Schmid Timothy EVP, WW Chair, MedTech | Sale | 13,625 | $244.20 | $3,327,225 | |
| Feb 18, 2026 | Schmid Timothy EVP, WW Chair, MedTech | Sale | 8,998 | $244.53 | $2,200,281 | |
| Feb 17, 2026 | Swanson James D. EVP, CIO | Sale | 20,521 | $242.70 | $4,980,447 | |
| Feb 17, 2026 | Wolk Joseph J Exec VP, CFO | Sale | 19,241 | $242.99 | $4,675,371 | |
| Feb 17, 2026 | Wolk Joseph J Exec VP, CFO | Sale | 24,961 | $242.68 | $6,057,535 | |
| Feb 17, 2026 | Wolk Joseph J Exec VP, CFO | Sale | 33,386 | $242.75 | $8,104,452 | |
| Feb 17, 2026 | Wolk Joseph J Exec VP, CFO | Sale | 12,066 | $242.87 | $2,930,469 | |
| Feb 17, 2026 | REED JOHN C EVP, Innovative Medicine, R&D | Sale | 2,283 | $243.00 | $554,769 | |
| Feb 17, 2026 | REED JOHN C EVP, Innovative Medicine, R&D | Sale | 29,927 | $243.00 | $7,272,261 | |
| Feb 17, 2026 | REED JOHN C EVP, Innovative Medicine, R&D | Sale | 21,721 | $243.00 | $5,278,203 | |
| Feb 17, 2026 | Broadhurst Vanessa EVP, Global Corp Affairs | Sale | 6,197 | $243.39 | $1,508,288 | |
| Feb 13, 2026 | Swanson James D. EVP, CIO | Sale | 22,191 | $243.71 | $5,408,169 | |
| Feb 13, 2026 | Swanson James D. EVP, CIO | Sale | 19,368 | $243.76 | $4,721,144 | |
| Jan 26, 2026 | Duato Joaquin CEO and Chairman of the Board | Sale | 48,782 | $221.48 | $10,804,432 | |
| Jan 26, 2026 | Duato Joaquin CEO and Chairman of the Board | Sale | 51,218 | $220.99 | $11,318,461 | |
| Nov 26, 2025 | MORIKIS JOHN G Director | Purchase | 1,250 | $206.15 | $257,688 | |
| Oct 17, 2025 | REED JOHN C EVP, Innovative Medicine, R&D | Sale | 21,721 | $192.71 | $4,185,793 | |
| Sep 04, 2025 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Sale | 56,471 | $177.81 | $10,040,883 | |
| Aug 22, 2025 | Duato Joaquin CEO and Chairman of the Board | Sale | 125,824 | $179.21 | $22,548,655 | |
| Aug 15, 2025 | Wolk Joseph J Exec VP, CFO | Sale | 16,820 | $176.91 | $2,975,571 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.